885-12-1 Usage
Description
2-(1H-pyrrol-1-yl)isoindoline-1,3-dione is a heterocyclic chemical compound characterized by a molecular formula of C13H8N2O2. It features a pyrrole ring fused with an isoindoline-1,3-dione ring, which endows it with unique structural and property attributes. 2-(1H-pyrrol-1-yl)isoindoline-1,3-dione holds promise for applications in organic synthesis and pharmaceuticals, given its potential for biological activities and its intriguing chemical structure, making it a valuable subject for research and development in drug discovery and design.
Uses
Used in Organic Synthesis:
2-(1H-pyrrol-1-yl)isoindoline-1,3-dione is used as a key intermediate in the synthesis of various organic compounds due to its reactive functional groups and the versatility of its heterocyclic structure, which can be further modified to produce a range of derivatives with different properties and applications.
Used in Pharmaceutical Industry:
2-(1H-pyrrol-1-yl)isoindoline-1,3-dione is used as a lead compound in drug discovery for its potential biological activities. Its unique structure allows it to interact with biological targets, making it a candidate for the development of new pharmaceutical agents with specific therapeutic effects.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, 2-(1H-pyrrol-1-yl)isoindoline-1,3-dione is used as a scaffold for the design of novel molecules with potential therapeutic applications. Its heterocyclic nature provides a foundation for the attachment of various functional groups, which can enhance its pharmacological properties and improve its efficacy as a drug candidate.
Used in Drug Discovery and Design:
2-(1H-pyrrol-1-yl)isoindoline-1,3-dione is utilized as a target molecule in the research and development of new drugs. Its chemical structure offers opportunities for optimization and modification to enhance its pharmacokinetic and pharmacodynamic profiles, making it a valuable asset in the quest for innovative therapeutic agents.
Check Digit Verification of cas no
The CAS Registry Mumber 885-12-1 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 8,8 and 5 respectively; the second part has 2 digits, 1 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 885-12:
(5*8)+(4*8)+(3*5)+(2*1)+(1*2)=91
91 % 10 = 1
So 885-12-1 is a valid CAS Registry Number.
885-12-1Relevant articles and documents
Synthesis method of remdesivir intermediate triazinamine derivative
-
, (2021/04/10)
The invention discloses a synthesis method of a remdesivir intermediate triazinamine derivative. The remdesivir intermediate triazinamine derivative is prepared by adopting a unique synthesis method. The invention solves the problems of expensive raw materials, large amount of wastewater in the production process and the like in existing reaction of a remdesivir intermediate triazinamine derivative, and provides the novel synthesis method of the remdesivir intermediate triazinamine derivative, wherein the synthesis method has the advantages of simple preparation method, cheap and easily available raw materials, greatly reduced production cost, less wastewater and the like; the synthesis method is never reported in the prior art, is a brand-new preparation method of the remdesivir intermediate triazinamine derivative, and provides a new synthesis idea for similar compounds of remdesivir.
HETEROCYCLIC COMPOUNDS
-
Page/Page column 83, (2018/07/29)
The present invention relates to compounds of the general formula (1) wherein the variables are defined as given in the description and claims. The invention further relates to uses of and to, processes and intermediates related to compounds of the general formula (I), wherein Q is wherein the substituents of I, Ia and Ib are as defined in description and claims.
PYRROLOPYRIDAZINE JAK3 INHIBITORS AND THEIR USE FOR THE TREATMENT OF INFLAMMATORY AND AUTOIMMUNE DISEASES
-
Page/Page column 73, (2012/10/07)
Disclosed are compounds of Formula (I), and pharmaceutically acceptable salts thereof. The compounds of formula (I) inhibit tyrosine kinase activity of JAK3, thereby making them useful for the treatment of inflammatory and autoimmune diseases.
